Given LFS is associated with many different tumor types, and given that somatic TP53 alterations are very common in tumors, our approach for the assessment of germline VUS in TP53 in the context of LFS required the presence of personal and family history suggestive of LFS. The gene discussed is TP53; the disease is neoplasm.